TABLE 1.
Impact of the FUS treatment through conventional analysis using the cerebellum as the reference region to compute the SUVr.
| SUVr-treated hippocampus/EC |
SUVr untreated hippocampus/EC |
|||||
| Patient ID | Baselinea | Post-treatmentb | % change from baselinec | Baselined | Post-treatmente | % change from baselinef |
| 1 | 1.792 | 1.569 | −12.44% | 1.72 | 1.559 | −9.36% |
| 2 | 1.471 | 1.386 | −5.78% | 1.438 | 1.445 | 0.49% |
| 3 | 1.799 | 1.766 | −1.83% | 1.705 | 1.721 | 0.94% |
| 4 | 1 | 0.983 | −1.70% | 1.011 | 1.043 | 3.17% |
| 5 | 0.905 | 0.906 | 0.11% | 1.048 | 1.083 | 3.34% |
| 6 | 1.265 | 1.048 | −17.15% | 1.294 | 1.192 | −7.88% |
Columns indicates, respectively, the SUVr for the treated and the untreated hippocampus/EC for each participants at baseline (a and d) and post-treatment (b and e). The percentage change from baseline (c and f).